what is the most performance mid cap stock between may 30 2012 and june 30 2013

ACADIA Pharmaceuticals (ACAD) had the highest return between May 30, 2012 and June 30, 2013 by a mid-cap US stock, returning 1,196.4%.

ASSETDATE% RETURN
ACADIA Pharmaceuticals (ACAD)
5/30/2012 - 6/30/2013
1,196.43%
Sarepta Therapeutics (SRPT)
5/30/2012 - 6/30/2013
792.93%
Vipshop (VIPS)
5/30/2012 - 6/30/2013
476.22%
Nexstar Broadcasting (NXST)
5/30/2012 - 6/30/2013
431.89%
Addus HomeCare (ADUS)
5/30/2012 - 6/30/2013
410.08%
Radian (RDN)
5/30/2012 - 6/30/2013
358.32%
Ligand Pharmaceuticals (LGND)
5/30/2012 - 6/30/2013
198.01%
Travere Therapeutics (TVTX)
5/30/2012 - 6/30/2013
192.11%
Vera Therapeutics (VERA)
5/30/2012 - 6/30/2013
180.95%
KB Home (KBH)
5/30/2012 - 6/30/2013
158.65%
JOYY (JOYY)
5/30/2012 - 6/30/2013
155.52%
Ambarella (AMBA)
5/30/2012 - 6/30/2013
150.82%
Axos Financial (AX)
5/30/2012 - 6/30/2013
149.02%
Option Care Health (OPCH)
5/30/2012 - 6/30/2013
143%
MGIC Investment (MTG)
5/30/2012 - 6/30/2013
139.93%
HCI (HCI)
5/30/2012 - 6/30/2013
137.57%
RH (RH)
5/30/2012 - 6/30/2013
134.01%
Archrock (AROC)
5/30/2012 - 6/30/2013
130.11%
Terawulf (WULF)
5/30/2012 - 6/30/2013
129.06%
GameStop (GME)
5/30/2012 - 6/30/2013
124.64%
Lithia Motors (LAD)
5/30/2012 - 6/30/2013
122.89%
Generac (GNRC)
5/30/2012 - 6/30/2013
122.53%
CVR Energy (CVI)
5/30/2012 - 6/30/2013
119.54%
Cytokinetics (CYTK)
5/30/2012 - 6/30/2013
114.26%
Prestige Brand (PBH)
5/30/2012 - 6/30/2013
113.79%
Mid-cap stocks are treated as having a market cap between $2B and $10B.